Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in Egypt.

Home | go to homepage
SCIENCE
  • SCIENCE
  • Cardiovascular
    • Cardiovascular
    • Thrombosis
      • Thrombosis
      • Caprini risk assessment model
      • Padua risk assessment model
      • Thromboprophylaxis in non-cancer surgical patients Case presentation Prof. Mario Siradella
      • Surgery for benign disease: Case presentation Prof. Juan Arcelus
      • VTE and bleeding risk assessment in the surgical patient. Prof. Joseph Caprini
    • Hypertension
      • Hypertension
      • ESH - ISH 2021/ Sanofi Hypertension Symposium Introduction
      • ESH - ISH 2021/ Sanofi Hypertension Symposium - Panel Disscussion
      • ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Based Scenarios
      • ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Study
      • ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Study
    • Dyslipidemia
      • Dyslipidemia
      • ODYSSEY OUTCOMES: Sub-analysis of the effect of Alirocumab in patients with CABG
      • ODYSSEY OUTCOMES: Sub-analysis of the effect of Alirocumab in elderly patients
      • Effect of Alirocumab on Mortality After Acute Coronary Syndromes
      • Polyvascular Disease Subanalysis
      • PACMAN AMI
      • PACMAN AMI: KOL Interview
    • Atherothrombosis
      • Atherothrombosis
      • Insights and impacts from the HOST-EXAM trial
      • Insights and impacts from the TALOS-AMI trial
  • Diabetes
    • Diabetes
    • Diabetes Your Type
    • Risk Stratification of Individuals with Diabetes before Ramadan
    • Management of Diabetes during Ramadan
    • Diabetes Overview, Complications and Guidelines
    • The BRIGHT Study
    • Sanofi's Insulin Legacy & Heritage
      • Sanofi's Insulin Legacy & Heritage
      • A legacy and heritage in insulin
      • Our Insulin Campus
    • Time in Range
      • Time in Range
      • Time In Range Infographics
      • Time in Range Study
      • The value of time-in-range as a glycemic biomarker
  • Rare Diseases
    • Rare Diseases
    • Management of Gaucher Disease
    • Clinically multidisceplinary management
    • An Overview over LSDs
    • Insights on Gaucher disease - Genetic prespective
    • Delayed Diagnosis of MPS1
    • Overview of MPS1
    • Diagnosing Gaucher Disease
    • Overview of Gaucher Disease & Clinical picture
    • Gaucher : Molecular Based Definitions
    • MPS1 : Pathogentics
  • Vaccines
    • Vaccines
    • Effectiveness & duration of protection of one dose of a Meningococcal Conjugate vaccine
  • Asthma
    • Asthma
    • What’s the best way to talk about my Asthma?
    • I need a good asthma plan, but where do I start?
    • Optimal Asthma Control goes beyond Exacerbation Reduction
    • Low Lung Function contributes to the risk of future severe Exacerbation and Poor Asthma Control
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Cardiovascular
    • Cardiovascular
    • How to self-inject Clexane video
  • Diabetes
    • Diabetes
    • Toujeo Patient Support Program
    • Soliqua Patient Support Program
    • How to take Toujeo
  • Atopic Dermatitis
    • Atopic Dermatitis
    • Dupixent My Way Program
    • Atopic Dermatitis Patient Educational Flyer
  • Nasal Polys
    • Nasal Polys
    • Dupixent My Way Program
  • Asthma
    • Asthma
    • Dupixent My Way Program
    • Bronchial Asthma Patient Educational Flyer
    • Dupixent How to Use Patient Booklet
    • Dupixent FAQ Patient Booklet
PRODUCTS
  • PRODUCTS
  • Clexane®
    • Clexane®
    • Extended VTE prophylaxis in onco-surgical patients
    • Duration of treatment for VTE prophylaxis
    • Critical thrombotic period
    • One day surgery & fast track surgery thromboprophylaxis Guidelines
  • Soliqua®
    • Soliqua®
    • OAD Uncontrolled Patients
    • Basal Insulin Uncontrolled Patients
    • Premix Uncontrolled Patients
    • Soliqua 2 Pens Modeling and Dosing
    • Soliqua Useful Links
  • Depakine®
  • Dapaglif®
    • Dapaglif®
    • Dapaglif Family range (Dapaglif 10mg & Dapaglif plus XR)
    • Dapaglif plus XR (Dapagliflozin 10mg + Metformin 1000mg extended release) announcement
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Dupixent Asthma
      • Dupixent Asthma
      • Type 2 Asthma With Ocs Use
      • Type 2 Asthma With Comorbidities
      • Type 2 Asthma With Mixed Biomarkers
      • Type 2 Asthma With High Eos
      • Type 2 Asthma With High Ige
  • Menactra®
  • Hexaxim®
  • VaxigripTetra®
  • Toujeo®
    • Toujeo®
    • Time in Range Results
  • Praluent®
    • Praluent®
    • Know about praluent
  • Plavix
    • Plavix
    • The Cure Study
    • PCI Cure Study
EVENTS
Log-in
Register
Search
Home | go to homepage
Log-in
Register
Search
Home | go to homepage
SCIENCE
  • SCIENCE
  • Cardiovascular
    • Cardiovascular
    • Thrombosis
      • Thrombosis
      • Caprini risk assessment model
      • Padua risk assessment model
      • Thromboprophylaxis in non-cancer surgical patients Case presentation Prof. Mario Siradella
      • Surgery for benign disease: Case presentation Prof. Juan Arcelus
      • VTE and bleeding risk assessment in the surgical patient. Prof. Joseph Caprini
    • Hypertension
      • Hypertension
      • ESH - ISH 2021/ Sanofi Hypertension Symposium Introduction
      • ESH - ISH 2021/ Sanofi Hypertension Symposium - Panel Disscussion
      • ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Based Scenarios
      • ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Study
      • ESH - ISH 2021/ Sanofi Hypertension Symposium - Case Study
    • Dyslipidemia
      • Dyslipidemia
      • ODYSSEY OUTCOMES: Sub-analysis of the effect of Alirocumab in patients with CABG
      • ODYSSEY OUTCOMES: Sub-analysis of the effect of Alirocumab in elderly patients
      • Effect of Alirocumab on Mortality After Acute Coronary Syndromes
      • Polyvascular Disease Subanalysis
      • PACMAN AMI
      • PACMAN AMI: KOL Interview
    • Atherothrombosis
      • Atherothrombosis
      • Insights and impacts from the HOST-EXAM trial
      • Insights and impacts from the TALOS-AMI trial
  • Diabetes
    • Diabetes
    • Diabetes Your Type
    • Risk Stratification of Individuals with Diabetes before Ramadan
    • Management of Diabetes during Ramadan
    • Diabetes Overview, Complications and Guidelines
    • The BRIGHT Study
    • Sanofi's Insulin Legacy & Heritage
      • Sanofi's Insulin Legacy & Heritage
      • A legacy and heritage in insulin
      • Our Insulin Campus
    • Time in Range
      • Time in Range
      • Time In Range Infographics
      • Time in Range Study
      • The value of time-in-range as a glycemic biomarker
  • Rare Diseases
    • Rare Diseases
    • Management of Gaucher Disease
    • Clinically multidisceplinary management
    • An Overview over LSDs
    • Insights on Gaucher disease - Genetic prespective
    • Delayed Diagnosis of MPS1
    • Overview of MPS1
    • Diagnosing Gaucher Disease
    • Overview of Gaucher Disease & Clinical picture
    • Gaucher : Molecular Based Definitions
    • MPS1 : Pathogentics
  • Vaccines
    • Vaccines
    • Effectiveness & duration of protection of one dose of a Meningococcal Conjugate vaccine
  • Asthma
    • Asthma
    • What’s the best way to talk about my Asthma?
    • I need a good asthma plan, but where do I start?
    • Optimal Asthma Control goes beyond Exacerbation Reduction
    • Low Lung Function contributes to the risk of future severe Exacerbation and Poor Asthma Control
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Cardiovascular
    • Cardiovascular
    • How to self-inject Clexane video
  • Diabetes
    • Diabetes
    • Toujeo Patient Support Program
    • Soliqua Patient Support Program
    • How to take Toujeo
  • Atopic Dermatitis
    • Atopic Dermatitis
    • Dupixent My Way Program
    • Atopic Dermatitis Patient Educational Flyer
  • Nasal Polys
    • Nasal Polys
    • Dupixent My Way Program
  • Asthma
    • Asthma
    • Dupixent My Way Program
    • Bronchial Asthma Patient Educational Flyer
    • Dupixent How to Use Patient Booklet
    • Dupixent FAQ Patient Booklet
PRODUCTS
  • PRODUCTS
  • Clexane®
    • Clexane®
    • Extended VTE prophylaxis in onco-surgical patients
    • Duration of treatment for VTE prophylaxis
    • Critical thrombotic period
    • One day surgery & fast track surgery thromboprophylaxis Guidelines
  • Soliqua®
    • Soliqua®
    • OAD Uncontrolled Patients
    • Basal Insulin Uncontrolled Patients
    • Premix Uncontrolled Patients
    • Soliqua 2 Pens Modeling and Dosing
    • Soliqua Useful Links
  • Depakine®
  • Dapaglif®
    • Dapaglif®
    • Dapaglif Family range (Dapaglif 10mg & Dapaglif plus XR)
    • Dapaglif plus XR (Dapagliflozin 10mg + Metformin 1000mg extended release) announcement
  • Dupixent®
    • Dupixent®
    • Atopic Dermatitis
    • Dupixent Asthma
      • Dupixent Asthma
      • Type 2 Asthma With Ocs Use
      • Type 2 Asthma With Comorbidities
      • Type 2 Asthma With Mixed Biomarkers
      • Type 2 Asthma With High Eos
      • Type 2 Asthma With High Ige
  • Menactra®
  • Hexaxim®
  • VaxigripTetra®
  • Toujeo®
    • Toujeo®
    • Time in Range Results
  • Praluent®
    • Praluent®
    • Know about praluent
  • Plavix
    • Plavix
    • The Cure Study
    • PCI Cure Study
EVENTS
  • Log-in
  • Register
  • Search
    • Home
    • Products

    Products

    Our Products

    Learn More

    Clexane 20,40 mg API
    Clexane 60,80 mg API

    Learn More

    Mechanism of Action

    Learn More

    Dupixent API

    Learn More

    Soliqua API

    In Range Study Results

    Learn More

    Dapaglif API

    Learn More

    Menactra API

    Learn More

    Hexaxim API

    Learn More

    VaxiGripTetra API

    Home | go to homepage
    • Privacy Policy
    • Terms & Conditions of Use
    • Cookie Policy
    • Sitemap